Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Nitiss

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Molecular Biosciences|April 25, 2022
SUMO: A Swiss Army Knife for Eukaryotic TopoisomerasesYilun Sun, John L Nitiss, Yves Pommier
Frontiers in Molecular Biosciences|May 15, 2023
Editorial: The repair of DNA-protein crosslinksYilun Sun, John L Nitiss, Yves Pommier
Cell Research|February 2, 2010
UnTTrapping the ends: a new player in overcoming protein linked DNA damageKarim Bahmed, Karin C Nitiss, John L Nitiss
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Yeast Tdp1 regulates the fidelity of nonhomologous end joiningKarim Bahmed, Karin C Nitiss, John L Nitiss
DNA Repair|August 23, 2019
DNA Damage by an essential enzyme: A delicate balance act on the tightropeKarin C Nitiss, John L Nitiss, Leslyn A Hanakahi
Molecular Pharmacology|May 13, 2008
Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressorsAlexander Stepanov, Karin C Nitiss, Geoffrey Neale, et al.
Nucleic Acids Research|October 12, 2010
End-processing during non-homologous end-joining: a role for exonuclease 1Karim Bahmed, Aman Seth, Karin C Nitiss, et al.
Molecular Pharmacology|September 6, 2005
Activation of the unfolded protein response is necessary and sufficient for reducing topoisomerase IIalpha protein levels and decreasing sensitivity to topoisomerase-targeted drugsMiranda D Gray, Melissa Mann, John L Nitiss, et al.
Nature Reviews. Molecular Cell Biology|September 22, 2016
Roles of eukaryotic topoisomerases in transcription, replication and genomic stabilityYves Pommier, Yilun Sun, Shar-Yin N Huang, et al.
Current Protocols in Pharmacology|September 28, 2011
Assessing sensitivity to antibacterial topoisomerase II inhibitorsSonia K Morgan-Linnell, Hiroshi Hiasa, Lynn Zechiedrich, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Molecular Biosciences|April 25, 2022
SUMO: A Swiss Army Knife for Eukaryotic TopoisomerasesYilun Sun, John L Nitiss, Yves Pommier
Frontiers in Molecular Biosciences|May 15, 2023
Editorial: The repair of DNA-protein crosslinksYilun Sun, John L Nitiss, Yves Pommier
Cell Research|February 2, 2010
UnTTrapping the ends: a new player in overcoming protein linked DNA damageKarim Bahmed, Karin C Nitiss, John L Nitiss
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Yeast Tdp1 regulates the fidelity of nonhomologous end joiningKarim Bahmed, Karin C Nitiss, John L Nitiss
DNA Repair|August 23, 2019
DNA Damage by an essential enzyme: A delicate balance act on the tightropeKarin C Nitiss, John L Nitiss, Leslyn A Hanakahi
Molecular Pharmacology|May 13, 2008
Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressorsAlexander Stepanov, Karin C Nitiss, Geoffrey Neale, et al.
Nucleic Acids Research|October 12, 2010
End-processing during non-homologous end-joining: a role for exonuclease 1Karim Bahmed, Aman Seth, Karin C Nitiss, et al.
Molecular Pharmacology|September 6, 2005
Activation of the unfolded protein response is necessary and sufficient for reducing topoisomerase IIalpha protein levels and decreasing sensitivity to topoisomerase-targeted drugsMiranda D Gray, Melissa Mann, John L Nitiss, et al.
Nature Reviews. Molecular Cell Biology|September 22, 2016
Roles of eukaryotic topoisomerases in transcription, replication and genomic stabilityYves Pommier, Yilun Sun, Shar-Yin N Huang, et al.
Current Protocols in Pharmacology|September 28, 2011
Assessing sensitivity to antibacterial topoisomerase II inhibitorsSonia K Morgan-Linnell, Hiroshi Hiasa, Lynn Zechiedrich, et al.
Pageof 7